Stock 4142 ADIMMUNE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Adimmune Corporation

Equities

4142

TW0004142005

End-of-day quote Taiwan S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
28.55 TWD +0.35% Intraday chart for Adimmune Corporation +0.35% -13.88%
05-15 Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-28 Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
An unknown buyer acquire 2.14% stake in Adimmune Corporation from BioEngine Technology Development Inc. for NTD300 million.
CI
Adimmune Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Adimmune Corporation Announces Change in Representative of its Institutional Director
CI
Adimmune Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Clover Bio Signs Exclusive Deal to Distribute Influenza Vaccine in China; Shares Climb 3%
MT
Clover Biopharmaceuticals, Ltd. Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China
CI
Tranche Update on Adimmune Corporation's Equity Buyback Plan announced on November 11, 2022.
CI
Adimmune Corporation's Equity Buyback announced on November 11, 2022 has closed with the repurchase of 5,000,000 shares, representing 1.17% for TWD 182.07 million.
CI
Adimmune Turns Profitable in January-September
MT
Adimmune Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Adimmune Corporation announces an Equity Buyback for 5,000,000 shares.
CI
Adimmune Corporation authorizes a Buyback Plan.
CI
Adimmune : The Company is invited to the online institutional investor conference hosted by Cathay Securities Corporation
PU
Adimmune Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Adimmune : announces financail statements of 2022 second quarter.
PU
Adimmune : To announce the completion status of execution of the stock repurchase
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4142 Stock
  4. News Adimmune Corporation